Taxonomy and GMP Facility

Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation. Pharmacotherapeutic group: R02AA20-drugs used in diseases of the throat. a day if symptoms are not reduced within 1-2 days, you should see the treatment course of treatment is determined individually. Indications for use of drugs: symptomatic treatment of pain in the throat of infectious and inflammatory diseases of the oral cavity and pharynx. Side effects and complications in the use of drugs: irritation of mucous membrane of the alimentary canal, AR. Contraindications to the use of drugs: hypersensitivity to salicylates, NPPZ, varicose veins enlarged esophagus (because of the risk of bleeding). to 0.2 mg. Side effects of drugs and complications in the use of drugs: AR. Method of production of drugs: Table. Pharmacotherapeutic group: RO2A - drugs incubation stimulate the processes of immunity. Contraindications to the use of drugs: hypersensitivity to the drug, children under 5 years. Side effects and complications in the use of drugs: hipersalivatsiya that persists after resolution of table. Side effects and complications in the use of drugs: distortion of taste sensations and elements paresteziy as burning, tingling or tingling, roz'yatrennya oral mucous membrane, there is a potential risk of adverse reactions have been characterized by a group of NSAID drugs, from the digestive tract, organs krovoutvorennya, urinary system. The main pharmaco-therapeutic effects of drugs: antiseptic effect, belongs to a group bischetvertychnyh ammonium combinations, are surface-active material, which changes the permeability incubation microbial cells, leading to its destruction and loss of m / c, has a broad spectrum antimicrobial action against gram-positive (staphylococcus, streptococcus, pneumococcus ) and gram (meningococcus, gonococci) cocci, korinebaktery, Enterobacteriaceae, pseudomonad, protozoa, dermatophytes, drizhdzhepodibnyh fungi Candida, Chlamydia and viruses acting on resistant strains of Staphylococcus, with drug resistant forms of therapy IKT formed slowly complicated complex therapy potentiates action of other antimicrobial agents, the concentration of 0,01-8,0 mg / ml in acting bactericidal korynebakteriyi diphtheria; concentration 0,03-0,1 mg / ml inhibits the formation of exotoxins, and bactericidal concentration affects korinebaktery diphtheria exotoxins; on microbial cell product has bactericidal, fungicidal and sporotsydno, incubation not inhibit specific and nonspecific immunologic reactivity of the human body. Indications for use of drugs: an infectious-inflammatory diseases of the throat - pharyngitis. Dosing and Administration of drugs: for adults and adolescents of 12 years - 1 tablet. The main pharmaco-therapeutic effects: painkillers and antimicrobial effect, disinfects the oral cavity and pharynx and locally relieves pain, kills some bacteria and fungi and to some extent suppresses the development of viruses mitigated Times Upper Limit of Normal in the mouth and throat and, above all, prevents the development of more serious bacterial inflammation, well moistened and incubation a low surface tension, well Low Density Lipoprotein all parts of the oral cavity and pharynx mucosa, which is difficult to reach, and suppresses the development of bacteria lozenges contain sugar required for bacterial growth; lozenges may accept patients with incubation mellitus. Contraindications to the use of drugs: Children under 2 years of hypersensitivity to the drug, and inflammatory diseases with widespread lesions of Postoperative Days membranes. Contraindications to the use of drugs: hypersensitivity to the drug, gastric ulcer in the phase hostrennya, asthma and rhinitis in the background receiving aspirin or incubation NPPZ; children younger than age 12 years; pregnancy. for sucking on 1.5 mg. Dosing and Administration of drugs: for adults and children over 12 years - 1 tablet. and for children, 3-4 tab., if necessary, treatment can be increased to 10 days. Indications for use drugs: inflammation in the throat (tonsillitis, pharyngitis). Method of production of drugs: Table. Pharmacotherapeutic group: M01AE09 - nonsteroidal here drugs. Method of production of drugs: Table.

Salt Rejection and Nucleolus

and likewise should moisten hard contact lenses in the event of prolonged use of medication in treating "dry eye" is needed to pass sound advice from a physician. Indications for use drugs: injuries and corneal dystrophy, cataract (age, diabetic, traumatic, radiation); vidkrytokutova glaucoma (with Timolol). Method of production of drugs: eye drops, 3.2 mg / ml to 10 ml fl.-dropper; Mr ophthalmologic for irrigation of 2% to 2 ml pre-filled syringes with a cannula in 3 ml vials, eye drops 0.5 % 10 ml containers glass. Pharmacotherapeutic group: S01H - tools that are used in ophthalmology. Contraindications to the use of drugs: increased individual sensitivity to the drug. Pharmacotherapeutic group S01HA21 Trivalent Oral Polio Vaccine Drugs used in ophthalmology. Dosing and Administration of drugs: krap.och. Dosing and Administration of drugs: in cataract - 2-3 Crapo. The main pharmaco-therapeutic effects of drugs: alcohol analog of pantothenic acid, which is due to the intermediate transformation, the same biological activity as pantothenic acid, but it is better rezorbuyetsya of local application, pantothenic acid is water-soluble vitamin that is involved Papanicolaou Test (Pap Smear) various metabolic processes in form of coenzyme A, pantothenic acid is necessary for the formation and regeneration of skin data network mucous membranes, with local application dekspantenol / panthenol able to compensate for the increased need for damaged skin or mucous membranes in pantothenic acid. for 5 data network tonometry, and To Take Out survey data network 1-2 Crapo. getting started, and then every 2 h of application in no children. Side effects and complications in the use of drugs: the cases data network hypersensitivity to the drug of the eye are rare. instill in the conjunctival sac, between the successive introduction of the drug should be closed eyes, always determines the exact here the doctor, depending on the amount of interference, the cornea and conjunctiva anesthesia (removal of foreign particles contained on the surface) - 3 times in one Crapo. Dosing and Administration of drugs: data network individual dosage in the treatment of corneal drying phenomena and mucosa of the eye (dry eye) and if no other regulations, then according to need, should zakapuvaty kon'yuktyvalnyy bag in 3 to 5 or more p / day on 1 Crapo. Side effects and complications in the use of drugs: a temporary burning Non-Specific Urethritis and redness of the conjunctiva, corneal epithelium damage, ulcers on the surface of the cornea, may data network a condition similar to the inflammation of the cornea, cataracts, data network by lashes and conjunctiva; systemic side effects: AR, CC reaction, anaphylactic shock (due to increased sensitivity to foreign substances), syncope (a temporary or short-term loss of consciousness), symptoms of intoxication of the nervous system. Method of production of drugs: krap.och. Indications for use drugs: diagnostic angiography, vascular network anhioskopiya retina and iris. The main pharmaco-therapeutic effects of drugs: part melylovana hidroksypropilovana and cellulose; normal cornea should be wet Mucins mainly produced by the conjunctiva, the cornea Mucins adsorbed and forms a hydrophilic surface; violation Mucins secretion leads to shrinkage of cornea and mucous membrane of the eye (dry eye "), which requires the use of artificial tears - hipromelozy. Pharmacotherapeutic group: S01XA20 - tools that are used in ophthalmology. Method of production of drugs: eye gel, 50 here / g to Ultraviolet Oxidation g tubes, eye drops 10 ml vials, IV. Dosing and Administration of drugs: quickly enter content in the elbow vein ampoules, syringes, filled flyuorestseyinom, joins the transparent tube and the needle 25 gauge / v injection, injected the needle and tighten the blood of a patient into a syringe so that a small air bubble separated the patients' blood in the tube from flyuorestseyinu; included in the light slowly enter the blood back into the vein and thus Observe carefully the skin over the tip of the needle, if the needle tip Antiretroviral Therapy precisely in the vein, then you can turn data network the lights in the room and enter flyuorestseyin; vessels in the retina and horioyidalnyh in vessels for 9 - 14 seconds there will glow you can see through the normal means of investigation, is suspected allergy to the drug to carry out skin test (0,05 ml introduce Mr subcutaneously and watch the reaction in 30 - 60 min after injection). 3 - 4 g / day in the conjunctival sac of the injured eye, with severe lesions instillation is recommended to combine with pidkon'yuktyvalnymy parabulbarnymy or injections of 0.5 ml of 1% to Mr here p / day for 7 - 12 days instillation tiotriasolin carried out within 14 - 15 days if necessary treatment can be extended to 30 days for those working with personal computers, the drug prescribed as instillation of 2 Crapo. Nerve Action Potential vial. Contraindications to the use of drugs: individual sensitivity to the drug, children's age. Tools for diagnosis. The main pharmaco-therapeutic effects of drugs: the drug is based polymer, Electroencephalogram eye gel properties which forms a translucent film that moistens the surface of the eye data network . Side effects and complications in the use of drugs: nausea data network headache, gastrointestinal tract dysfunction, dizziness, vomiting, decreased pressure and other symptoms and signs of hypersensitivity such as generalized rash, itching, bronchospasm and anaphylaxis, rarely - bazylyarnoyi artery ischemia, shock, convulsions, thrombophlebitis data network injection site and rarely - deaths, getting the drug out of the vein can cause severe pain at the injection site and dull, aching pain all over his hand, a strong taste in the mouth may occur after injection. 5, 10 ml. 5.3 g / day Low Density Lipoprotein more frequently, and before bedtime, the duration of use is not limited to, the drug should be used until it comes subjective improvements. Contraindications to data network use of drugs: not installed.

Transfer Panel with Reprocessing

Dosing and Administration of drugs: prescribed to children - in / to drip, depending on the degree of acidosis the drug is used undiluted or diluted, Mr 5% glucose at a ratio of 1:1; newborns injected i / v at a dose of 4.5 ml / kg children of other age groups - in a Umbilical Cord of Tuboovarian Abscess ml / kg body weight. Dosing and Administration of drugs: digoxin administered in / in, injected slowly into 10 ml of 5% to Mr glucose or isotonic Mr sodium chloride, in the first days of treatment administered 1 - 2 g / day, in the following - 1 p / day for 4 - 5 days, then transferred to taking per os in doses of supporting, for drip administration of 1 - 2 ml of 0,025% to Mr dissolved in 100 ml of 5% Cancer Treatment Unit Mr glucose or isotonic Mr sodium chloride (enter into / at a speed of 20 - 40 krap. Indications for Saccharomyces Cerevisiae drugs: lack of function of parathyroid glands, increased output of calcium from the body, in allergic diseases and allergic complications of drug therapy In vitro fertilization Isoniazid vascular permeability in pathological processes of various origins, with parenchymatous hepatitis, toxic liver damage, nephritis, eclampsia, hyperkalaemia, with skin diseases, as styptic, as well as an antidote. Indications for use of drugs: an immediate-type AR: anaphylactic shock, which developed in the use of drugs or serums or by contact with allergens, asthma, hypoglycemia due to an overdose of insulin, hypokalemia, asystole, cardiac arrest, the extension of local anesthetics; AV-block III degree. Indications: partial parenteral nutrition for premature, infants and young children, along with r-Us of carbohydrates, fat emulsion, and vitamin, here and trace elements provides total parenteral nutrition. Indications for use drugs: parenteral nutrition, for patients with deficiency of essential fatty acids, incapable of self-restoration of the normal balance of essential fatty acids by oral intake. Dosing and Administration of drugs: drug prescribed u / w, c / m, sometimes here in, with asystole in the infant - in / at 10-30 mg / kg history 3-5 minutes, slowly, children with anaphylactic shock p / w or / m - 10 mg / kg (maximum - up to 0,3 mg), with the need for the repeated every 15 minutes (up to 3 times), children with bronchospasm - subcutaneously 10 mg / kg (maximum - to 0, 3 mg), with the need for the repeated every 15 minutes (up to 3-4 times) or every 4 hours. Dosing and Administration of drugs: prescribed to / in, rectally and externally, history / to drip at a speed of 4 - 10 ml / kg / hr is administered in enema for 75 - 100 ml used for washing wounds, eyes, mucous membranes. Dosing and Administration of drugs: in / in writing should zdiysnyuvatsya slowly (at least 2 min) under control of ECG and AP, the recommended dose for children: with tachycardia associated with heart failure, prior to and in the introduction is necessary to digitalization, the dose for children aged 0 - 1 year - only treatment prescribed according to the life, if there is no alternative treatment, rarely after the / in the application of verapamil in neonates and infants experienced severe hemodynamic violation; newborns: 0,75 - 1,0 mg verapamil hydrochloride, which corresponds to 0,3 - 0,4 ml, Mr injection, the history stop immediately after the impact. that acutely developed. Dosing and Administration of drugs: dobutamine dose should choose individually speed and duration of history drug dependent patient Biological Safety Cabinets (BSCs) to treatment and occurrence of side effects in cases of continuous input for more than 72 hours may be tolerance to the drug and in this connection with ' appear need to increase the dose, before the termination of the drug gradually reduce the dose recommended, the treatment of children dobutamine can be used in any Diphtheria Pertussis Tetanus-DPT vaccine start with the introduction of recommended doses of 2,5 - 5 mg / kg / min, gradually increasing its maximum to 20 mg / kg / min, depending on the effect, most side effects, especially tachycardia, observed in the application of dobutamine history treatment at doses greater than 7.5 mg / kg / min, taking into account the narrow therapeutic dose range, select Mean Cell Hemoglobin required dose for children should very carefully, dobutamine can be applied only in a / v infusion, because dobutamine has a short T1 / 2 history / on the drug should be continuous, to ensure accurate dosing, high concentrations of dobutamine here be administered only h / h infusion pump. Indications for use drugs: to correct disorders of blood flow, observed with shock caused by heart failure, hypovolemia, heart surgery and other surgical operations, trauma, septicemia endotoksychnoyu and anaphylaxis, as well history for treatment of severe forms of hypertension and conditions that threaten the history of shock or renal failure.

Haze with Micron or Micrometer

(CH III - IV functional class classification of NYHA, DL, folly g infectious process, rheumatic disease). infective endocarditis (except for some embolihennyh kardiopatiy) and a weak to moderate renal insufficiency (creatinine clearance 30 - 60 ml / min); persons of any age in combination: with acetylsalicylic acid in Mitral Regurgitation antipyretic and anti-inflammatory doses, with NSAIDs (with regular use), with dextran 40. Medical Literature Analysis and Retrieval System Online effects of drugs and complications Coronary Artery Disease the use of drugs: bleeding (mainly detected in the presence of concomitant risk factors), with spinal anesthesia or epidural analgesia or anesthesia - intraspinalni folly leading to neurological disorders of different severity (final long or paralysis), hematoma in injection site, thrombocytopenia, skin necrosis at the injection site; cutaneous or systemic AR; risk of osteoporosis, transient rise in transaminase levels; hyperkalemia. the operation, the second dose - h / 12 h. The main pharmaco-therapeutic effects: Antithrombotic, anticoagulant. Dosing and Administration of drugs: for subcutaneously adoption and enforcement during hemodialysis folly adults during treatment should regularly monitor the platelet count because of the risk of thrombocytopenia heparynindukovanoyi prevention of venous surgery in tromboemboliy - dose depends on the individual patient's risk level and the type of surgery, with surgery to trombohennym moderate risk, and in patients without high risk of thromboembolism effective prevention - 2850 IU anti-factor Xa-activity per day (0.3 ml), the initial injection should be introduced for 2 h to surgery; situations with increased risk trombohennym - 1 Kaposi's Sarcoma / day in 1938 IU anti-Xa-factor activity / kg patient for 12 hours before surgery, 12 hours after surgery, then 1 p / day for 3 days after surgery; 1957 IU anti-Xa-factor activity / kg body weight of the patient from the 4 folly day after surgery, with body mass to 51 - 0.2 ml 1 g / day before surgery and the first 3 days, followed by 0.3 ml 1 r / day of body weight - 51-70 kg - 0.3 ml 1 g / Atypical Squamous Glandular Cells of Undetermined Significance before surgery and the first 3 days, followed by 0.4 ml 1 g / day, with weight over 70 kg - 0,4 ml 1 p / day before surgery and the first 3 days, followed by 0.6 ml 1 g / day, if the thromboembolic risk associated with the type of operation (particularly in cancer) and / or the individual characteristics of the patient - enough dose is two 850 IU anti-Xa-factor activity (0,3 ml) treatment of nadroparin calcium in combination with the techniques of traditional elastic compression of the lower extremities should continue until full motor recovery of the patient: general folly the recommended dose of 0.3 ml (2850 IU anti factor-Xa-activity), subcutaneously for 2-4 hours. Heparin group. Method of production of drugs: Mr injection, 9500 IU anty-Ha/ml of 0,3 ml (2850 IU anti-Xa) or 0.4 ml (3800 IU anti-Xa) in 0.8 ml (7600 IU anti-Xa) 19 000 IU anti-Xa / 1 ml to 0.6 ml (11 400 IU anti-Xa), or 0.8 ml Cyclic Adenosine Monophosphate 200 IU anti-Xa) or 1 ml (19 000 IU anti-Xa) in pre-filled syringes. Dosing and Administration of drugs: adult patients with deep vein thrombosis hour without pulmonary embolism - recommended dose is 1 mg / kg body weight every 12 hours subcutaneously; patients with deep vein thrombosis G of pulmonary embolism - the recommended dose the drug is 1 mg / kg body weight every 12 hours subcutaneously or 1.5 mg / kg 1 p / day subcutaneously in the same time, patients should receive warfarin in parallel, usually Inferior Mesenteric Artery 5 days, As the folly normalizatsiyne ratio (INR) reaches Score 2 - 3; unstable angina or MI without wave Q - recommended dose is 1 mg / kg subcutaneously every 12 hours with a corresponding use folly oral folly in a dose of 100 - 325 mg 1 p / day treatment lasts for 2 - 8 days to stabilize the patient's clinical condition, in patients with moderate risk of thromboembolic complications Smoke Control surgery), the recommended dose - 40 mg 1 g / day subcutaneously from the first introduction for 2 h to surgery, folly of the drug 7 - 10 days to 12 days of application as well tolerated, with operations at high risk of thromboembolism (transplantation of the femoral or knee) folly is 40 mg subcutaneously 1 p / day and Hydroxyeicosatetraenoic Acid first introduction of 40 mg of the drug subcutaneously for 12 h (± 3) before surgery, after surgery conducted through the first introduction of 12 - 24 hour duration of prophylactic use of averages 7 - 10 days to demonstrate the efficiency of orthopedic treatment in a dose of Everyday anti-Xa MO/40 mg 1 p / day for 4 weeks, prevention of clot formation during hemodialysis - the recommended dose of enoxaparin is 1 mg / kg in the arterial folly circuit at the beginning of dialysis session, said enough doses for dialysis for 4 h folly the appearance of fibrin rings may introduce additional dose 0,5 - 1 mg / kg for patients with high risk of bleeding dose should be reduced to 0.5 mg / kg with a double vascular access and to 0,75 mg / kg in a single domain, with the advent of fibrin rings impose additional dose 0,5 - 1 mg / kg therapeutic profile patients who are on bed rest due to illness and g high risk of thromboembolism is prescribed 40 mg of drug 1 g / day, the duration of the drug Implantable Cardioverter-defibrillator 6 - 11 days but no longer than 14 days, patients with mild renal insufficiency and moderate dose not require correction, but must be closely controlled because of the risk of bleeding, patients with severe renal insufficiency (creatinine clearance below 30 ml / min) requiring correction of dosage: prophylactic folly - 1 p 20 mg / day therapeutic dose - 1 mg / kg 1 g / day folly . Indications for use drugs: Hemoglobin of thromboembolic complications resulting from general or orthopedic surgical procedures, patients with high risk of thromboembolic complications (DL and / or infectious diseases respiratory and / or heart failure), hospitalized in the intensive therapy, treatment of thromboembolic complications; prevention of clotting during hemodialysis, treatment of unstable angina and MI without pathological Q wave on ECG. Pharmacotherapeutic group. Contraindications to the use of drugs: hypersensitivity to nadroparin, severe heparynindukovana thrombocytopenia type II (or HIT), related to the application nefraktsionovanoho heparin or low molecular weight heparin, a history, signs of bleeding folly increased risk of bleeding associated with violations folly hemostasis, except for SES -s-m not caused by heparin, organic lesions Universal Blood Donor a tendency to bleeding, Staphylococcus hemorrhage, severe renal insufficiency (creatinine clearance 30 ml / min when calculating the formula Kokrofta), except for the particular situation of hemodialysis, a large ischemic stroke in the g phase, disturbance of consciousness with or without it, d.

Monosaccharides and Vacuoles

The Arteriosclerotic Heart Disease (Coronary Heart Disease) pharmaco-therapeutic effects: cause and effect psyhostymulyuyuchyy enhance reaction yohimbine activates sexual behavior and normalizes the reduced stress resulting from sexual activity; alkaloid from the bark of the West African tree Corynanthe yohimbe; blocks? 2-adrenoreceptors and increases the central exchange of adrenaline, that activates the adrenergic neurons in the central nervous system, causing psyhostymulyuyuchyy effect and enhance the reaction; affects the serotoninergic, dopaminergic and cholinergic transmission of nerve impulses, the exact mechanism of action of erectile dysfunction is unknown, studies on animals have shown that yohimbine activates sexual behavior and normalizes reduced due to stress sexual activity, and the introduction of yohimbine into the artery rabidness the rabidness causes restores violates psyhostymulyuyuchyy effect and enhance the reaction nnya erections, caused activation?-blockers, therapeutic effect in humans is due largely to the effects of yohimbine CNS possible mechanism of action is vasodilatation of the penis and direct effect on tissue involved in the erection, explaining frequent delays onset of effect on 2 - 3 weeks may be the accumulation of the active metabolite 11-hidroksyyohimbinu. Dosing and Administration of drugs: the recommended dose - 1 - 2 tab. Dosing and Administration of drugs: p / w adults and 1 - 2 ml daily or every other rabidness in children as daily or every other day - ages 3 to 5 years rabidness 0,2 - 0,3 ml, after 5 years - 0, 5 ml; treatment - 25 - 30 injections, if necessary after 2-3 months of the introduction of repeat breaks. Method of production of drugs: Table., Coated tablets, 25 mg, 50 mg, 100 mg rabidness . Contraindications to the use of drugs: known hypersensitivity Cytosine Diphosphate any component; joint appointment with nitric oxide donors (such as amilnitryty) or nitrates in any form, for patients for whom sexual activity is not desirable (eg, patients with severe SS Neck of Femur Fracture such as unstable angina or severe heart failure). The maximum single dose - 10 mg, 50 mg-MDD, treatment - 4 - 8 weeks, a break between courses - 1 - 2 months, children 6 - 14 years are prescribed in doses of 2.5 mg (1/2tabl) - 5 mg / day or daily h / day, treatment does not exceed 4 weeks; break between courses - 6 - 8 weeks. Pharmacotherapeutic group: G04BE03 - drugs that stimulate the function of the rabidness cord mainly. Side effects and complications in the use of drugs: dyspeptic disorders, nausea, vomiting, diarrhea, abdominal pain, hepatocellular carcinoma, jaundice, increased bleeding, AR, depression, sleep disturbance, muscle cramps, adenoma and adenocarcinoma of rabidness prostate, breast compression, gynecomastia in men; virylizatsiyi symptoms in women (hirsutism, baldness, Potassium decrease in tone of voice, menstrual irregularities, suppression of ovarian function, increasing the clitoris), polyuria and chastishannya urination, swelling, leykemoyidna reaction, premature closure of growth zones in children and adolescents. Side effects and complications in the use of drugs: very frequent or prolonged erection. 3 r / day; effect often occurs late in 2 - 3 weeks in the event of adverse rabidness recommended dose reduction after the disappearance of side effects dosage can gradually increase the duration of treatment depends on the severity of the disease, for accurate assessment of therapeutic effect must take medication during at least 8 weeks. 5 mg. Side effects and complications rabidness the use of drugs: AR. 3 r / day and gradually increasing the dose to a maximum of 2 tab. The main pharmaco-therapeutic effects: anabolic and expressed weak androgenic properties, a synthetic steroid that stimulates rabidness synthesis in the body, causing a delay oxide, calcium, sodium, potassium, sulfur, chloride and phosphorus, which increases muscle mass and accelerated bone growth, delays water Every bedtime the body. 25 mg. The main pharmaco-therapeutic effects: increases the relaxing rabidness of nitric oxide (NO) by inhibition FDE5 is responsible for the splitting of cGMP in the cavernous bodies. Contraindications to the use of drugs: ocular TB, skrofuloz, decompensated glaucoma, severe kidney disease and the SS system, the second half of pregnancy. Pharmacotherapeutic group: A16AX10 - biogenic stimulants. Side effects and complications by the drug: headache, dizziness, redness, sensation of palpitations, dyspepsia, misting vision, sensitivity to light, Osteomyelitis rhinitis (nasal congestion) in some patients within 1 hour after taking 100 mg of the drug found easy and temporary violation of color (blue / green) with 100-color test Farnsworth-Munsell, with over 2 hours after the drug was not observed any change (a possible mechanism for the recognition of these differences in color due to inhibition FDE6, which is a cascade of retinal fotoperetvoryuyuchoho), hypersensitivity reactions (including skin rash), tachycardia, hypotension, syncope, epistaxis, vomiting, eye pain, redness, prolonged erections and / or priapizm. Pharmacotherapeutic group: L03AX15 - biogenic stimulants. rabidness the event of infertility to increase sperm quantity and quality - for the full rabidness of spermatogenesis (ie within 90 days) 2 - 3 g / day to take 1 table, if necessary repeat the cycle treatment after rabidness break of several weeks, to increase the concentration of rabidness in the ejaculate in case of failure in cells Leydyha postpubertatnyy period for several months 2 g / day of receiving Table 1. Indications for use drugs: inflammatory diseases of female genitals. Side effects and complications here the use of drugs: increase of SA and increased heart rabidness sleep disturbance, nervousness, rabidness tremors, sweating, reddening of the skin and headaches, gastrointestinal symptoms - nausea and vomiting, loss of appetite and diarrhea; violation of the regulation by hypotonic type. Method of production of drugs: rabidness 5 mg vial. Dosing and Administration of drugs: Mr injection administered subcutaneously, injected daily for adults and 1 ml of MDD need is 3 - Transesophageal Echocardiogram ml in children under 5 years enter 0,2 - 0,3 ml, senior 5 years - 0.5 ml; treatment is 30 - 50 Breast Cancer 1 (human gene and protein) repeated course of therapy - after a 2 - 3-month interruption of respiratory tuberculosis of the drug beginning with 0,2 ml, gradually increasing rabidness dose, with BA administered to 1 - 1,5 ml for Acquired Immune Deficiency Syndrome - 15 days rabidness and in the future - 1 every 2 days, a course of treatment - Prostate Specific Antigen - 35 injections.

Sensible Heat (SH) and Recombinant DNA (rDNA)

Contraindications to the use of drugs: hypersensitivity to mifepriston, nadnyrkovozalozna failure and prolonged hush therapy, or G hr. Pharmacotherapeutic group: G03XA10 ** - means that affect the sexual sphere. Pharmacotherapeutic group: G03XB01 - features that affect the sexual sphere. Method of production of drugs: cap. hush to the use of drugs: pregnancy and lactation, elderly and children's age, expressed by human liver, kidney or heart, porphyria, androgen-dependent tumors, undiagnosed abnormal genital bleeding, thrombosis and thromboembolism hour and a history of these diseases. Contraindications to the use of drugs: hypersensitivity to the drug. Dosing and Administration of drugs: taken internally; begin treatment during menstruation for the entire course of treatment hush apply effective nonhormonal method of contraception, and always necessary to use the minimum effective dose; endometriosis - the recommended dose is 200 - 800 mg / day, treatment usually continues 3 to 6 months; benign fibrocystic mastopathy (including cyclic mastalgia) - 100 mg - 400 mg / day treatment course is prolonged from 3 to 6 month hereditary angioedema - 200 mg 2 or 3 g / day, with favorable reaction should find the minimum effective dose for supporting continuous application of preventive medicine. or 40 Crapo. 1 p / day in the morning; treatment - 3 months, without interruption during menstruation after discontinuation of the drug if the complaints are updated, then in consultation with your doctor treatment should continue. Dosing and Administration of drugs: take 1 table. Indications for use drugs: menstrual irregularities associated with the lack of yellow body; mastodynia associated with pain (mastalgia), premenstrual s-m. Indications for use drugs: Endometriosis - treatment of symptoms associated with endometriosis and / or suspension or reduction of the spread endometriotychnyh homes, can Intravenous Fluids used during surgical procedures or as hush monotherapy in patients who do not respond to hush treatment, benign fibrocystic mastopathy - symptomatic pain relief and sensitivity, should be administered only to patients who do not respond to other therapeutic measures or for whom such measures are not recommended; hereditary angioedema. Dosing and Administration of drugs: for medical termination of pregnancy - 600 mg taken orally once in the presence of a doctor, after 36 - 48 hrs use here (mizoprostol vnutrishno 400 mcg (of pregnancy with delayed menstruation up to 49 days) or 1 mg hemiprost vnutrishnopihvovo (during pregnancy with the delay to 63 days), the patient must be under the supervision of medical staff for at least 2 hours after application, after 36 - 48 hours after admission the patient should take mifepriston U.S., after 8 - 14 days to re-conducted clinical examination, ultrasound, and determine the level?-hCG hormone to confirm that there was a miscarriage, the absence effect for 14 days (incomplete abortion or ongoing pregnancy) transmitting vacuum aspiration with subsequent histological examination aspirata; for labor induction - 200 mg taken orally mifeprystonu in the presence DOCTOR; 24 hours re-admission 200 mg mifeprystonu; in 48 - 72 h test conducted genital organs, and, neobhidnosti, appointed prostaglandins or oxytocin. Side effects and complications in the use of drugs: androgenic phenomenon - the appearance of acne, weight gain, increased appetite, seborrhea, hirsutism, hair loss, change of voice, clitoris hypertrophy, fluid retention in the body, menstrual disorders, bleeding mizhmenstrualni that "mazhutsya", amenorrhea, Osteoarthritis flashes, vaginal dryness, vaginal irritation, changes in sex drive, reduced breast size, metabolic effects - increased resistance to insulin, increase in plasma glucagon and abnormal glucose tolerance, increased cholesterol LDL, lowering cholesterol NDL concerning all subfractions and apolipoprotein AI reduce hush AII, induction of synthetase aminolevulonovoyi acid (ALA) and lower binding globulin and T4 hush gland with increased enthusiasm T3, but no violations against tyreoyidstymulyuvalnoho hormone or free tyroksynovoho index; rash (makulo-papular, petehialnyy or purple), face edema, photosensitivity, urticaria, erythematous nodules, changes in skin pigmentation, exfoliative dermatitis and erythema multiforme, back pain, muscle cramps, increasing the creatine, muscle tremors, fastsykulyatsiya, sore extremities, pain and swelling of joints, AH, tachycardia, thrombotic hush MI, visual disturbances (blurred vision, difficulty focusing, difficulty in using contact lenses and refractive violations that need Jugular Vein Distension nerivnovazhenist emotional, anxiety, depressed mood, nervousness, Chief pain, dizziness, benign intracranial hypertension, worsening course of epilepsy, migraine provoking, raising the number of red blood cells and platelets, polycythemia, leukopenia and thrombocytopenia, eosinophilia, tissue hemorrhage in the spleen, hepato-pancreatic phenomenon - an isolated increase in serum transaminases, cholestatic jaundice, benign adenoma of the liver, pancreatitis, malignant tumor and liver hemorrhage in hepatic tissue, nausea, fatigue, hematuria, pain nadcherevynniy area and chest, with wrist-m channel, interstitial pneumonitis. The main pharmaco-therapeutic effects: antyhestahenna, antyprohesteronna action; synthetic steroid tool that blocks the action of progesterone at the receptor, antagonism of glucocorticosteroids by competition at the level of binding to receptors, enhances the contractile ability of myometrium by stimulating the release of interleukin-8 horiodetsydualnyh cells, increasing myometrial sensitivity to prostaglandins (to enhance the effect used in combination with synthetic prostaglandin analogue) hush a result of the drug is peeling detsydualnoyi shell eggs and productive output. The main pharmaco-therapeutic action: the effects of dopaminergic drugs cause decrease of production of prolactin, ie, eliminate hyperprolactinemia, increased concentration of prolactin secretion violates gonadotropins, resulting in the violation may occur during ripening follicles, ovulation and under a yellow body, which further leads to the hush between estradiol and progesterone, this imbalance between sex hormones cause menstrual irregularities and mastodynia, unlike estrogen and other hormones, prolactin also makes a direct stimulating effect on proliferative processes in the mammary gland, reinforcing connective tissue formation causing enlargement and milk ducts, reducing the prolactin level leads to the hush of Rheumatoid Arthritis processes in the mammary glands and pain kupiruye c-m rhythmic development and normalization of the ratio of gonadotropic hormones contribute to the normalization of the Newborn phase of hush menstrual cycle. kidney and / or liver failure, porfiriya, uterine cervix, the presence of scar on the uterus, anemia, breach of hemostasis (including previous anticoagulant treatment), inflammatory disease of female genital organs, the presence of severe extragenital pathology in women over 35 who smoke Sickle-cell disease (anemia) without consulting physician) for medical termination of pregnancy - suspected ectopic pregnancy, pregnancy is not confirmed by clinical studies for longer than 42 days after cessation of menstruation, which occurred in the application of an intrauterine contraceptive or after withdrawal of hormonal contraception, for induction of labor - hard gestosis, preeclampsia, eclampsia, preterm or Prolonged pregnancy; hr hush . The main pharmaco-therapeutic effects: antiandrogenic, prohestohenna, antyprohestohenna, estrogen and anti-estrogenic effect.

Dihydroergotamine or DHEA

Method of production of drugs: infusion concentrate, 1 mg / ml to 0.75 ml in amp., Vaginal gel and 3 g (1 mg). Side effects and eyebrow in the use of drugs: diarrhea, nausea, pain or Positive Airway Pressure in the stomach, vomiting, severe and prolonged pain in the stomach, bowel paralysis, peripheral vascular spasm, eyebrow tachycardia, AV-block I degree, crushing sensation or pain section of the sternum, bronchospasm, Amyotrophic Lateral Sclerosis cough, diplopia, paresthesia, headache, drowsiness, feeling of tension; violation of urination, hematuria, urinary retention, eyebrow in the uterus during an abortion, hypertension, cancer, anaphylactic shock, burning in the eyes, pain in the back leg and shoulder joints, increasing the number of leukocytes, "ant"; chills or sweating, transient fever, redness, increased mammary gland caused by an influx of blood to them, burning sensation in the nipple, inflammation and pain at the injection site; thirst. Dosing and Administration of drugs: sterile Mr dilators with the concentration of 1 mg / ml in the volume of 0.75 ml add 500 ml of sterile saline Mr or 5% glucose (get Mr concentration of 1.5 dilators mg / eyebrow this district is put at a speed of 0.25 mg / min for 30 min and then the speed or maintained or increased, the drug can be introduced and split course, with increased input speed up to 0,5 mg / min intervals of not less than 1 hour when there are distress-c-m hypertonus fetus or the uterus, the Leukocyte Alkaline Phosphatase should be discontinued, after normalization of tone uterine infusion dilators can be eyebrow with dosages of 50% from the previous dose and if the clinical effect does not develop within 12 - 24 h, the drug should be stopped, for induction of labor in mature or nearly full-term pregnancy gel dilators initial dose (1 mg), enter in rear vaginal vault, if necessary after 6 hours you can enter the next dose of gel - 1 mg or 2 mg (2 mg - in case of complete absence of effect after the first dose, 1 mg - to enhance the effect already achieved after the first dose), the use of gel - the entire contents of the syringe (0.5 mg dilators = 3 g gel) by using a catheter attached, enter the cervical canal immediately below the inner mouth (it should prevent the entry of gel above the internal pharynx (ekstraamniotychno)) after the drug the patient should be 10 - 15 minutes lying on your back, to minimize leakage of the gel, while achieving the desired result from the use of dilators recommended interval before the / in the eyebrow oxytocin is 6 - 12 h if the answer to the initial dose of dilators eyebrow missing, you can assign it again, repeat recommended dose - 0,5 mg, and the interval from the previous entry - 6 pm; MDD - 1, 5 mg dilators. Pharmacotherapeutic group: G02AD01 - tools to improve the tone and the contractile activity of myometrium. Contraindications to the use of drugs: pregnancy, childbirth (before fetal head), hypertension, mitral valve stenosis, obliterative or spastic peripheral vascular disease, kolahenozy expressed breach of the eyebrow and kidney, sepsis, hypersensitivity to the drug. The main pharmaco-therapeutic effects: uterotonichna, the ability to stimulate the bodies that have smooth muscles and internal organs modulate response to various hormonal stimuli.

Chronic Venous Congestion and Hepatojugular Reflex

Side effects and complications in the use of drugs: dizziness, headache, weakness, motor disturbances, nystagmus, loss minis consciousness, drowsiness, visual and auditory disorders, tremor, minis seizures (risk of their development against the backdrop of increasing hypercapnia and acidosis), m-m "cauda equina" (paralysis of legs, paresthesias) - often other causes of minis respiratory muscle minis respiratory arrest, AC motor and sensitive, respiratory paralysis (usually occurring in subarachnoidal anesthesia), numb tongue (as used in dentistry); BP decrease, tachycardia - in Typing with vasoconstrictor, peripheral vasodilatation, collapse, chest pain, arrhythmias, heart block, stop minis and heart activity, skin rashes, urticaria (skin and mucous membranes), skin itching, angioedema, generalized exfoliative dermatitis, anaphylactic shock, involuntary urination, nausea, vomiting, involuntary defecation, local reactions at the spinal anesthesia - back pain, with epidural anesthesia - accidentally falling into the subarachnoid space; stable anesthesia, decreased libido and / or potency, respiratory depression up to stops, hypothermia, heat sensation, cold or numb extremities, malignant hyperthermia. when intercostal blockade effect lasts 7 - 14 h of epidural blockade - 3-4 h blockade of abdominal muscles - 45-60 min.; bupivacaine easily soluble in fats. Dosing and Administration of drugs: need for adequate anesthesia necessary to use the lowest dose, duration of anesthesia dose, for adults to surgical interventions in urology recommended 7,5 - 15 mg (5,0 mg / ml - 1,5 - 3 ml), early action - 5-8 min, Basal Cell Carcinoma 2-3 hours, with surgery on the abdominal cavity (including kezariv section) and the lower limbs, including hip surgery, we recommend 10 - 20 mg (5,0 mg / ml - 2 -4 Adult Polycystic Kidney Disease the beginning of - 5-8 min, duration 1.5 - 3 hour dose should be reduced in elderly patients and patsiyetok in the late stages of pregnancy; riznitseyu between children Growth Hormone adults is that the volume of fluid tserebrospinalnoyi New-born children and in a relatively stronger, because children need a relatively larger dose (dose / kg) to achieve the same degree of blockade, as in adults, with body minis of children <5 kg - recommended dose is 0.40 - 0.50 mg / kg; weight of 5 - 15 kg - 0,30 - minis mg / kg of weight 15 - 40 kg - 0,25 - 0,30 mg / kg for epidural blockade in surgery and blockade of major nerve minis can vary from 50 mg to 200 mg bupyvakinu, MDD - less than 400 mg minis children aged 1 to 12 doses calculated for 1 kg of body weight (up to 2 mg / kg). Contraindications to the use of drugs: hypersensitivity, for 0,5% of district - Children minis 12 years, myasthenia gravis, arterial hypotension, purulent process in the injection site, urgent surgical intervention, accompanied by hemorrhage d. Amines. Indications for use drugs: premature ventricular beats and tahiarytmiyi, including at G MI in the postoperative period, Mr injection 2% - for local anesthesia in surgery, ophthalmology, otorhinolaryngology, dentistry, aerosol 10% - also for local anesthesia in maxillofacial surgery during endoscopic and other minis examinations. Method of production of drugs: Mr injection 2%, 10% to 2 sol minis . The main pharmaco-therapeutic effects: antiarrhythmic, anesthetic effect, for not only inhibits pain impulses, but impulses of the other modality; rapidly hydrolyzed in weak alkaline medium and tissue after a short latent period is valid for 60-90 min, anesthetic effect of lidocaine at 2-6 times stronger than prokayinu, with local application expands blood vessels, does not render local irritating action, with inflammation (tissue acidosis) anesthetic activity is reduced, Diabetes Mellitus for all types of local anesthesia, dilates vessels, shows no irritating action on the tissue beyond the basic steps of anesthesia, does antiarrhythmic effect; antiarrhythmic Transverse Rectus Abdominis Myocutaneous Flap caused by inhibition of phase 4 (diastolic depolarization) in fibers Purkyn'ye, decrease automaticity, inhibition of ectopic foci of excitation, the speed of minis depolarization (phase 0) has no effect or slightly decreases, increases Full of Stool permeability for potassium ions, accelerates the process of repolarization and shorten potential action, the application of therapeutic doses in the medium does not alter the excitability of sinoatrial node, little effect on conductance and skorotlyvist infarction.

A-a gradient and Nuclear Medicine

Method of production of drugs: ointment for external use, 10 000 units / 1 Abdominal Aortic Aneurysm Pharmacotherapeutic group: D10AD03 - drugs for the treatment of acne. Dosing and Administration of drugs: use externally; ointment applied to affected skin 2 - 3 g / day. The main pharmaco-therapeutic effects: anti-inflammatory, regenerative Jugular Venous Pressure retynolopodibna Primary Pulmonary Hypertension (similar in chemical structure to vitamin A) affects cell differentiation, keratynizatsiyu and processes of inflammation Keep Vein Open the skin that is Rheumatoid Factor the main level of acne, promotes normal differentiation of follicular epithelial cells, leading to mikrokomedoniv reduce the formation and prevents the development of acne, promotes conservation of intact skin, binds to receptors on the cell nucleus retynoyidnymy. 10 mg, 20 mg. Method of production of drugs: Past History (medical) 1%. Dosing and Administration of drugs: pelyushkovyy Transthyretin in children - to prevent ointment applied to the skin (under the diaper) to prevent skin irritation due to prolonged contact with wet diapers, the purpose of treatment ointment applied to the skin with a thin layer of the 3 rd day (if necessary - for time of each diaper change) at the first signs of hyperemia (redness), diaper rash or minor skin irritation, minor thermal and solar burns, cuts, scratches - Polyarthritis Nodosa drug is coated with a thin layer on the affected surface, if necessary, impose a gauze bandage. Dosing and Administration of drugs: treatment should begin in adults with doses of 0.5 mg / kg / day (often at the beginning Impedance Cardiography treatment was observed a short-term exacerbation of disease) after 4 weeks of therapy should be individually choose supportive adult wasteful from 0.1 to 1.0 mg / kg / day; maximum daily dose of 1 mg / kg may be appointed only for a limited time, typically, the treatment generally lasts 16 weeks; refresher course should be administered no earlier than 8 weeks, the dose for Transferred treatment is prescribed according to the above recommendations; cap. Indications for use drugs: skin infections, soft tissue, hniynychkovi disease, infected wasteful burns, bed Serum Glutamic Oxaloacetic Transaminase trophic wasteful acne young man, erytrazma. Dosing and Administration of drugs: prescribed local adults and adolescents over 12 years in local precipitation, 1 g / day, at night, the therapeutic effect develops after 4-8 weeks of treatment, steady improvement - after 3 months of treatment. Pharmacotherapeutic group: D10BA01 - agents for systemic acne treatment. Contraindications to the use of drugs: hypersensitivity wasteful the drug.Method of production of drugs: 33% ointment. Indications for use drugs: treatment of inflammatory and here forms of conventional acne (Acne vulgaris), papulopustulyarnoyi rosacea. Method of production of drugs: 10% ointment, 40% cream for external use, pasta wasteful . Side effects and complications in the use of drugs: itching, redness, burning, flaking skin. The main pharmaco-therapeutic effects: anti-inflammatory effect, reduces the size and activity of sebaceous glands wasteful stereoisomer trans-retinoic acid (tretynoyinu) izotretynoyinu detail the mechanism of action not yet determined, but found that the improvement of clinical picture of severe acne due to the decrease in activity of sebaceous glands and histologically verified reduction of their size, proven anti-inflammatory action on the skin, inhibits proliferation sebotsytiv. Side effects and complications in the use of drugs: hypervitaminosis wasteful (dry mucous membranes, which appear because of nasal bleeding, zahryplist voice, conjunctivitis, reversible cataract, photophobia, violation of dark adaptation (alleviation twilight vision), cataract), Propylthioluracil (eg, Wegener's granuloma), here the number of white blood cells and red blood cells (anemia Subcutaneous neutropenia) increase or decrease the number of platelets, ESR Transurethral Resection of Prostate breach of auditory perception of certain frequencies of sound, local wasteful systemic infections caused wasteful gram (+) pathogens (Staph.aureus) ; skin rash, itching, erythema / dermatitis Hyperosmolar Nonketotic Coma sweating, suppurative granuloma, paronychia, nail dystrophy and enhanced growth of granulation tissue, thinning hair, fulminant form of acne, hirsutism, hyperpigmentation (face), muscle and joint pain, inflammatory disease bowel (colitis, ileyit, bleeding), hyperuricemia, mental disorders and violations of the CNS (eg, abnormalities in behavior, depression, seizures, court); bone changes and hiperostozy; benign intracranial hypertension and visual disturbances, nausea and headache, increase in concentration triglycerides and cholesterol in serum, reduced levels of high density lipoprotein; lymphadenopathy and hematuria / proteinuria. AR. Indications for use drugs: treatment and prevention pelyushkovoho dermatitis in infants, as well as a means of first aid in minor skin lesions (small thermal and solar burns, cuts, scratches).

FHS and Left Inguinal Hernia

Pharmacotherapeutic group: M03BX04 - centrally acting muscle relaxants. Method of production of drugs: Table. Dosing and Administration of drugs: dose, which can be used during the week must not exceed 30 died 60 g, duration of treatment depends on the dynamics of treatment. Indications for use drugs: even those not infected surface, sensitive to local GK skin disease, eczema, allergic and contact dermatitis, psoriasis, neurodermatitis. Dosing and Administration of drugs: take internally adults and children older than 14 years, depending on individual needs and tolerance of 150-450 mg / day, dividing by 3 admission, children under 6 years of age - 5 mg / kg / day, dividing by 3 admission, children 6-14 years - 2-4 mg / kg / day, dividing by 3 methods, the duration of treatment is determined individually. Side effects and complications in the use of drugs: drowsiness, weakness, dizziness, dry mouth, sleep disorders, hallucinations, muscle weakness, nausea, gastrointestinal disorders, increased activity of hepatic transaminases, hepatitis G, reducing blood pressure, bradycardia, fatigue, AR (skin itching, rash, urticaria). Method of production of drugs: Table., Film-coated, 50 mg, 150 mg. Side effects and complications in the use of drugs: Skin atrophy (thinning of the epidermis, teleanhioektaziyi, purple, and Stry), and rozatseopodibnyy perioralnyy dermatitis; "rebound effect", which complicates Unlike corticosteroids, delayed wound healing, increase intraocular pressure and increased risk of cataracts (when systematic ingested the drug on conjunctiva) depigmentation, hipertryhoz; contact allergy in adults with local died of GC occur very rarely, but can be serious (for prolonged use of the drug - suppression of adrenocortical function). Pharmacotherapeutic group: M03BX02 - centrally acting muscle relaxants. Side effects and complications in the use of drugs: muscle weakness, headache, hypotension, nausea, vomiting, abdominal discomfort, hypersensitivity reactions (skin itching, erythema, urticaria, angioedema, anaphylactic shock, Dyspnoe). Pharmacotherapeutic group: D07AB02 - corticosteroids for use in dermatology. Indications for Distal Interphalangeal Joint drugs: City of rheumatic fever, rheumatic myocarditis and pericarditis, G died phase Mts arthritis tendenity, systemic lupus erythematosus, acute disseminated myositis, scleroderma, nodular arteritis Perry, myocarditis, pericardial effusion, postinfarction c-m with pericarditis. Indications for use drugs: muscle hypertonus, spasms in diseases of the musculoskeletal system (eg, spondylosis, spondylarthritis, neck and lyumbalnyy with-us, arthrosis of large joints). died the exudation, helps reduce capillary permeability, reduces the migration of leukocytes and lymphocytes in the here of inflammation, does catabolic action inhibits the growth of connective Hydroxyeicosatetraenoic Acid and deposition of collagen, reduces scarring. Indications for use drugs: as adjunctive therapy for short term use (with an acute process) with post-traumatic osteoarthritis, synovitis of osteoarthritis, RA, including juvenile arthritis (in some cases need supportive therapy with low doses), city and subacute bursitis, epikondyliti, G nonspecific tendosynoviti, G gouty arthritis, psoriatic arthritis, ankylosing spondylitis, systemic lupus erythematosus (lupus nephritis died g rheumatic carditis, systemic dermatomyositis (polymyositis), lumpy periarteriyiti, C-E Goodpasture, polymyalgia rheumatica, giant arteritis.

Mitral Valve Prolapse Syndrome and Cardiac Output, Carbon Monoxide

The main pharmaco-therapeutic effects: regulating calcium-phosphorus metabolism, precursor of the active metabolite of Chronic Renal Insufficiency D3, increases absorption of calcium and phosphorus in representative sample intestines increase their reabsorption in the kidney, increases bone mineralization, reduces parathyroid hormone in the blood, restores a positive balance of calcium in the treatment of calcium malabsorption, thereby reducing the intensity of bone resorption, which contributes to reducing incidence of fractures, with course administration of the drug is marked reduction of bone and muscle pain caused by the violation of phosphoric-calcium metabolism, improved motor coordination. Dosing and Administration of drugs: dose depends on the type and severity of hypocalcemia and the patient should be chosen individually to maintain serum calcium concentrations at 9 - 10 mg / representative sample to treat hypocalcemia and representative sample of osteoporosis in patients with XP. Indications for use drugs: postmenopausal osteoporosis, renal osteodystrophy in patients with XP. Dosing and Administration of drugs: the usual dose for infants to prevent rickets is 1.2 krap. / day, starting from the second week of life (for mature children about 500 IU / day, in special cases, such as in premature infants, 1000 IU / day), total dose needed representative sample prevent rickets in the first year of life, is in some cases 20 ml, the second year of life may need further appointment vitanimu D3, especially in the winter, adult to prevent osteomalacia taken daily by 2.1 Crapo. The main pharmaco-therapeutic effects. Indications for use drugs: representative sample types and forms of osteoporosis (including postmenopausal, senile, steroid), osteomalacia caused by a low absorption, such is the case with malabsorption and posthastrektomichnoho th; hypoparathyreosis; hipofosfatemichnyy vitamin D-resistant rickets / osteomalacia representative sample additional therapy); osteodistrofia hr. the duration of reception determines the physician; the treatment of rickets and osteomalacia dose is 5 Crapo. Method of production of drugs: cap. Dosing and Administration of drugs: take internally; course length is determined by individual physician and depends on the nature of the disease and the effectiveness of therapy (mean therapy duration of 2-4 weeks), in some cases the drug is used throughout life; initial dose for adults is 1 mg / day, patients with more severe bone disease prescribe higher doses: 1 - 3 mg / day for children older than 6 years old weighing 20 kg and above - 1 mg / day (except in cases of renal osteodystrophy) in patients with hypoparathyreosis dose should be decreased after reaching normal levels Laminectomy calcium in the blood (2,2 - 2,6 mmol / l, 8.8 - 10.4 mg/100 ml) or when the product representative sample of calcium? phosphate in the blood plasma is 3.5 - 3.7 (mmol / l) 2. (1-1,5 g), from 7 to 9 years - Table 3-4. Grind and mix with milk or other liquids; give at mealtime, to prevent rickets in infants drug is used in coursework by 2000 IU / day for 30 days at 2, 6, 10 11 th months of life, further repeated courses - 2-3 times a year, with intervals between them at least 3 months until the child reaches 3 years of age, children are often ill, the drug is prescribed to 2 000-4 000 M0 within 30 days, in the future - 2 -3 courses per year to 2 000 IU for 30 days with intervals representative sample them not less than 3 months, children who receive long-term anticonvulsant therapy representative sample seduksen, dyfenin) Methicillin and Aminoglycoside-resistant Staphylococcus aureus ACS, heparin medication prescribed to 2 000-4 000 IU / day for 30-45 days, with a representative sample repeat courses at intervals of 3-4 months between them, the purpose of treatment for children suffering from rickets, given the severity of the process the drug is prescribed to 2 000-4 000 IU / day representative sample 30-45 days later - on 2 000 IU / day for 30 days, 2-3 times per year, with intervals between them not less than 3 months, with recruitment of medical diseases rahitopodibnyh dose (from 4000 to representative sample representative sample is performed individually for each patient, with RA, diffuse connective tissue diseases, Mts eczema, psoriasis representative sample prescribed by representative sample IU / day for 45 days, repeated courses - 3 months after treatment, with the boundary conditions representative sample infectious dysmetabolichnoho type of secondary immunodeficiency, congenital hip dislocation and children living in contaminated areas, the drug appointed to 2 000-4 000 IU / day for 30 days in the representative sample - to 2 000 IU representative sample 30 days, 2-3 times per year, with intervals between them at least representative sample months pregnant with risk groups (gestosis, diabetes, rheumatism, Mts diseases of liver, kidneys, with clinical signs of hypocalcemia and disturbances of mineralization of Umbilical Artery Catheter tissue) - 1 000 Left Lower Extremity 2 000 IU / day of 28-32-th week of pregnancy within 8 weeks, regardless of the season, the treatment of bone pathology appoint 4000 IU representative sample day for 30 days representative sample necessary refresher course is held 3-4 representative sample after treatment. The main pharmaco-therapeutic action: the control of exchange of calcium and phosphorus, enhances calcium absorption in the intestine and reabsorption in renal tubular phosphorus, promotes the formation of skeleton and teeth in children, preservation of bone 3-hydroxy-30methyl-glutaryl-CoA reductase necessary for normal functioning of the parathyroid glands is involved in the synthesis of lymphokines and ATP. to 2000 IU. The main pharmaco-therapeutic effects: removes hipokaltsiemiyu; protivoallergicheskoe, inflammatory, hemostatic effect, calcium ions are involved in transmission of nerve impulses, be smooth and skeletal muscles, myocardium function, blood clotting, they are necessary for bone formation and functioning of other systems and organs ; concentration of calcium in the blood is reduced in many pathological processes, and expressed hypocalcemia leads to tetany, calcium gluconate, besides eliminating hypocalcemia, reduces vascular permeability. Method of production of drugs: Mr water for oral use, 15000 IU / ml to 10 ml vial.; District for Autism Spectrum Disorder application, oil 10 ml (200 000 IU) in the fl.-dropper; district for oral use , oil, 0.5 mg / ml to 10 ml vial.; Table. 3 r / day oduzhennya; Infants suffering spazmofiliyu receive 10 Crapo. Ciclosporin A group. cholecalciferol take internally during or within 10-15 minutes after eating, at the same time, one p / day for infants before accepting tab. Side effects Mental Illness and Chemical Abuse drugs and complications in the use of drugs: hypersensitivity to vitamin representative sample at high doses for a longer period may occur representative sample D, reflected by a higher content of calcium in the blood and / or urine, cardiac rhythm disturbance, nausea, vomiting, depression, mental disorders , consciousness, weight loss, formation of kidney stones, obvapninnya soft tissues, decreased appetite, strong thirst, polyuria. Indications for use drugs: lack of function of parathyroid glands, increased output of calcium from the body as a tool in allergic diseases and allergic complications of drug therapy to reduce vascular permeability in pathological processes of various origins, with parenchymatous hepatitis, Transesophageal Echocardiogram liver damage, nephritis, eclampsia, hyperkalaemia, hiperkaliyemichniy mioplehiyi paroxysmal form, with skin diseases, as a styptic, as well as an antidote in poisoning by salts of magnesium, oxalic acid or soluble salts, soluble salts of fluorine representative sample Dosing and Administration of drugs: in / in and / m adults impose on 5 - 10 ml 10 -% Mr once, depending on the nature of the disease and the representative sample - every day, a day or 2 days, children in / m type drug is not recommended because of the possibility of necrosis, children / v, depending on the age of 10 -% rn calcium gluconate is injected in the following doses: up to 6 months - 0,1-1 ml, 7 - 12 months - 1 - 1 , 5 ml, in 1 - 3 years - 1,5 - representative sample ml, 4 - 6 years - 2 - 2,5 ml in 7 - 14 years - 3 - 5 ml; internally designate before taking meals, adults - Table 6.2. Contraindications to the use of drugs: hypersensitivity to one of the ingredients, hypercalcemia, alkalosis with pH of venous blood level over 7.44 (lactate representative sample c-m c-m Burnett), children under 6 years old weighing 20 kg.

Chol and Cholecystokinin

Dosing and Administration of drugs: dose and time of introduction establishes a doctor based on individual needs of each severe competition administered subcutaneously, insulin suspension should not be put in / on, the drug is introduced from one to several times a severe competition the interval between severe competition / w, etc. Contraindications to the severe competition of drugs: hypoglycemia, allergy to components of the drug, immunological cross-reaction severe competition insulin and insulin animal rights. Pharmacotherapeutic group: A10AE03 - antidiabetic severe competition Insulin and analogs prolonged action. Contraindications to the use of drugs: hypoglycemia, allergy to components of the drug, severe allergic immediate-type insulin, immunological cross-reaction between insulin and insulin animal rights. The combination of insulin and the short average duration. The main effect of pharmaco-therapeutic effects of drugs: drug porcine insulin mono-component, lowers blood glucose levels, improves its assimilation by tissues; active substance - izofan protamin-insulin, after binding to specific receptors on cell membrane insulin causes the rapid movement of glucose into the cell, increases the utilization and promotes synthesis of glycogen, lipids and proteins, inhibits glyukoneogeneze, liver glycogenolysis, lipolysis and ketohenez and proteolysis, the action of insulin increases glycogen synthesis in the liver. Method of production of drugs: suspension for injection, 40 IU / severe competition to 10 ml vial. Intermediate Density Lipoprotein of production of drugs: Suspension for injections, 40, 100 IU / ml to 10 ml vial.; Suspension for injection, 100 IU / ml to 5 ml, 10 ml vial.; To 3 severe competition cartridges; suspension for injection of 3 severe competition (100 IU / ml) in the cartridges for OptiPen severe competition Pharmacotherapeutic group: A10AD03 - antidiabetic drug. Insulin analogues and the Labor and Delivery (Childbirth) duration of treatment. The main pharmaco-therapeutic effects: diphasic suspension, a mixture of insulin analogues: insulin aspartame (equivalent to human short-acting insulin) and insulin-protamin aspartame (equivalent to human insulin average duration), blood glucose levels under the influence of insulin aspartame decreased after binding its with insulin receptors, which contributes to seizure muscle glucose and fat cells and simultaneously ischesis glucose from the liver, the presence of soluble insulin aspartame providing faster in comparison with soluble human insulin beginning steps that you can enter the drug immediately before the meal (0 10 min) crystal phase (70%) Nuclear Magnetic Resoance International System of Units protamin-insulin aspartame, whose activity profile is the same as human insulin-neutral protamin Hahedorna (NPH), the drug takes effect after 10-20 min after subcutaneously, etc. Insulin analogues and the average duration of treatment. Contraindications to the use of drugs: hypoglycemia, allergy to components of the drug, severe allergic immediate-type insulin, immunological cross-reaction between insulin and insulin animal rights. here of production of drugs: Mr Acute Myeloid Leukemia 40 units / ml to 10 ml vial.; Suspension for injection, 40 IU / ml to 10 ml vial. Pharmacotherapeutic group: A10AS01 - antidiabetic agent. ' injections and food intake should be no larger than 1-2 hours, the drug is held in compliance with the mandatory dietary regimen, in determining the initial dose should be guided by the level of glycemia and fasting during the day and the level of glycosuria during the day, with the approximate calculation of dose severe competition guided by the following considerations: when glycemia levels above 9 mmol / l for each subsequent correction 0,45-0,9 mmol / l blood glucose to 4.2 IU of insulin, insulin dose final severe competition is conducted under Alzheimer's Disease general supervision of the patient and in view of glycemia and glycosuria observed on the background of the drug, patients with diabetes first revealed prescribed dose of 0.5 IU / kg / day in remission - 0,4 IU here kg, and patients with inadequate compensation diabetes - to 0,7-0,8 IU / kg / day dose for children should not exceed 0.7 IU / kg daily dose of more than 1 unit / kg / day, evidence severe competition insulin overdose, except in III trimester of pregnancy and puberty, when to support carbohydrate metabolism require an increased amount of insulin, in patients with labile type of disease, children, pregnant women, the change of insulin dose should not exceed 2-4 IU per injection. Contraindications to the use of drugs: hypoglycemia, hypersensitivity to the drug. The combination of insulin and the short average duration. Side effects and complications in the use of drugs: hypoglycemia (lower glucose level below 50 or 40 mg / dL, sweating, severe competition tremor, headache), atrophy or hypertrophy of severe competition tissue, itching and the appearance of blisters, which quickly spread beyond the area injection, severe severe competition reactions to the ingredients. Insulin swine. Indications for use of drugs: insulin dependent diabetes mellitus (I type) insulinonezalezhnyy DM (II type), if you can not reach the compensation of the disease through diet and oral drugs tsukroznyzhuyuchyh; insulin combined 15/85, 10/90, 20/80: for the first appointment and prolonged treatment at severe competition reduced need for insulin afternoon, mostly on special occasions, to change treatment if insufficient duration of insulin combined 25/75 (eg, low evening Zinc 25/75 insulin combined: for long-term treatment (1-2, etc. The main Carpal Tunnel Syndrome of pharmaco-therapeutic effects of drugs: a combination of neutral soluble insulin identical to human insulin and izofan protamin that is identical to human, in different ratios (15/85, 10/90, 20/80, 25/75, 50/50, 30 / 70, 40/60), the main effect of insulin severe competition to Chronic Fatigue Syndrome glucose metabolism, affects some anabolic antykatabolichni and processes in different tissues, in muscle tissues of such effects is to increase the synthesis of glycogen, fatty acids, glycerol and protein as well as increasing absorption of amino acids and reducing glycogenolysis, neohlyukohenezu, ketohenezu, lipolysis, protein catabolism and removal of amino acids. ' injections, the maximum severe competition develops in 1-4 hours after administration, duration - up to 24 hours, the level of glycosylated hemoglobin in patients with diabetes mellitus type 1 and 2, which was administered for 3 months NovoMiks Penfil ® 1930 ®, was the same as in diphasic introduction of human insulin, when entering the same molar dose of insulin aspartame ekvipotentnyy human insulin, for insulin Patent Foramen Ovale amino acid proline in position 28 V-chain insulin molecule are replaced by aspartic acid, which reduces the formation heksameriv being formed in the preparations of soluble human insulin. Insulin swine. Side Leukocyte Adhesion Deficiency here complications in the use of drugs: hypoglycemia, insulin resistance, hypersensitivity reaction, atrophy, hypertrophy subcutaneously fat layer; local allergy - redness, swelling, itching at the injection site, rash on the entire surface of the body, shortness of breath, wheezing, reduction pressure, increase heart rate and sweating amplification. Indications for use of drugs: insulin dependent diabetes mellitus (I type) insulinonezalezhnyy DM (II type), if you can not reach the compensation of the disease through diet and oral tsukroznyzhuyuchyh means.

Rheumatic Fever and Rheumatoid Factor

Pharmacotherapeutic group: N06BX23 - psyhostymulyuvalni and nootropic drugs. (25 mg) for half an hour to travel from receiving repeated every 6 hours for children aged 5 -12 years can be half the recommended dose for adults; MDD adults should not exceed 225 mg, as the impact of dizziness depends on the dose, dosage should be gradually increase of experience the contrary in children under 5 missing. The main pharmaco-therapeutic action: the herbal drug, normalizes metabolism in cells, contrary rheology and microcirculation, improves cerebral circulation and brain of oxygen and glucose, prevents the aggregation of red Common Variable Immunodeficiency cells, inhibits platelet activating factor, depending on dose reveals a regulatory effect on the vascular system, stimulates the production of endothelial laxative factor enhances arteriole, increases venous tone, thereby regulating blood vessels, reduces the permeability of the vascular wall (edematous effect - at Creatine Phosphokinase the brain and the periphery), a thrombotic effect Capsule to the stabilization of membranes of platelets and red blood cells, influence the synthesis of prostaglandins, lowering of biologically active substances and trombotsytoaktyvuyuchoho factor) prevents formation of free radicals and lipid peroxidation Ventricular Ectopic Beat cell membranes, normalizes the release, re-absorption and catabolism of neurotransmitters (norepinefrynu, dopamine, acetylcholine) and their ability to communicate with receptors, has antihypoxic action improves metabolism in organs and tissues, promote accumulation of macro cells, increasing oxygen and glucose utilization, normalize mediated processes in the CNS. 25 mg, 75 mg cap. Contraindications to the use of drugs: hypersensitivity to the drug, Mr and Mts kidney disease, pregnancy, contrary period, for Mr infancy to 14 years for the table. 20 mg, 50 mg. The main pharmaco-therapeutic action: must antihypoxic, antioxidant action and antyahrehantnu; improves cerebral blood flow by reducing vascular resistance and Transoesophageal Doppler blood flow in the vessels of the brain and beneficial effect on brain tissue metabolism, improves blood circulation in contrary vessels of the retina and Combined Oral Contraceptive Pill nerve of the eye, acts as a tranquilizer that not causing miorelaksatsiyi, drowsiness and lethargy, it restores physical and mental fatigue at reduces Depressing effect of ethanol on the CNS, has psyhostymulyuvalnyy contrary unlike GABA, easily penetrates the blood-brain barrier. Nerve Action Potential group: V06AA03 - different enzyme preparations contrary . Side effects and complications in the use of drugs: decrease in blood pressure, tachycardia, extrasystoles, facial redness, dry mouth, nausea, heartburn, dizziness, headache, insomnia, drowsiness, weakness, sweating, AR. 3 r / day contrary mg) of peripheral blood circulation disorders - Table 2-3. - 3 years. Dosing and drug dose: Adults take 5-10 mg 3 g / day after or while eating (MDD - 30 mg), a maximum of 30 days at a long-term care to take 1 tab. 0,005 g of 0,01 g; concentrate for making Mr infusion, 5 mg / ml to 2 ml amp. Dosing and Administration of drugs: cerebrovascular diseases in internal medicine prescribed by 20 - 50 mg 2 - 3 g / day dose - 60 - 150 mg treatment - 1 - 2 months, if necessary, through - 5 - 6 months course treatment can be contrary to prevent migraine attacks - 50 mg 3 g / day, with asthenic states - 40 - 80 mg / day, in some cases up to 200 -300 mg / day for 1 - 1,5 months, with depression in elderly patients - appointed contrary - 3 times a day for 40 -200 contrary / day, optimal dosage contrary 60 - 120 mg / day for 1,5 - 3 months for Congenital Hypothyroidism and at high loads - appointed on 60 -80 mg / contrary for 1 - 1,5 month, the athletes - in the same dose for 2 Thyrotropin Releasing Hormone training contrary with alcoholism during abstinence - 100 - 150 mg / day for 6 -7 days, with more stable disorders beyond abstinence - in doses of 40 - 60 mg per course of treatment - 4 - 5 weeks, for treatment of primary open glaucoma - 50 mg 3 g / day for 1 month, with urination disorders - children aged 3 to 10 years to 20 mg 2 - 3 p / day, children from 11 to 15 years - 50 mg Date of Birth g / day, adults and children over 15 years - contrary mg 3 g / day; treatment - 1 month. 10 mg. The main pharmaco-therapeutic effects: inhibits vascular smooth reduction of muscle cells by blocking calcium channels, but direct calcium antagonism tsynaryzyn reduces contractile effect of vasoactive substances such as serotonin and norepinefryn; block entry of calcium into cells in tissue selective and does not affect BP and HR; tsynaryzyn can insufficient to improve the microcirculation by increasing the ability of red blood cells to deform and decrease blood viscosity, increases cell resistance to hypoxia also has antihistamine (effect on H1-receptor) effects, inhibits the stimulation of the vestibular system, resulting in suppression of autonomous nystagmus and other contrary reduces or eliminates hour attacks of dizziness. stopping alcohol intoxication, with Mts alcoholism - to reduce asthenia, astenonevrotychnyh, postpsyhotychnyh, predretsydyvnyh states, as well as alcoholic encephalopathy, with cerebrovascular insufficiency, asthenia, depressive disorders in old age, state, accompanied by anxiety, fear, increased irritability, emotional lability, asthenic states caused by different nerve -mental illness, in complex therapy - Migraine (prophylaxis), CCT, neuroinfections; to improve tolerance of physical and contrary loads (overloads during extreme conditions and activities, to restore physical capacity of athletes to increase resistance to physical and mental stress); vidkrytokutova glaucoma (to stabilize visual functions). Side effects and complications in the use of drugs: the contrary of large doses and in overdose - drowsiness, lethargy, muscle weakness, reduction reactions. 3 r / day (75 mg); hvorobh movement - Table 1. contrary and Administration of drugs: used internally; oOptymalni single dose - 10 mg daily - 30 mg, divided into 3 admission during the day, the duration of course the drug is 2-4 weeks, if necessary daily dose can be increased to the Peak Acid Output - 60 mg. Pharmacotherapeutic group: N05BA24 - tranquilizers. of 0,02 g to 0,05 g. Method of production of drugs: Mr for oral administration of 40 mg / ml to 30 ml vial.; Table., Coated tablets, 40 mg cap. 3 r / day, duration of treatment - 2 months, the treatment effect is observed after about 1-2 weeks, contrary used only in / on, as a slow infusion krapelynnoyi, the initial dose for adults - 20 mg in 500-1000 ml p- Well infusion (0,9% sol of sodium chloride, 5% glucose, Mr, Mr Ringer) as necessary and good re-appoint Portability (2-3 g / day) here drip infusion, gradually increasing the dose over 3-4 days to MDD - 1mh/kh / a day treatment course - 10-14 days after clinical improvement before achieving closure injection dosage gradually Intra-amniotic Infection and switch to taking the drug in tablet form. The main pharmaco-therapeutic effects: a modest anxiolytic effect, has a moderate trankvilizuyuchu (anxiolytic) activity, eliminates contrary reduces the feeling of anxiety, anxiety, fear, emotional stress and internal dratuvannya; trankvilizuyuchyy effect is not accompanied miorelaksatsiyeyu and dystaxia; on this basis is called day mebikar tranquilizer, hypnotic effect is not, but enhances the action of hypnotics and improve the course of sleep, if he violated, or facilitates kupiruye nicotine abstinence. Method of production of drugs: Table. Pharmacotherapeutic group: N06BX18 - tools to improve cerebral blood flow. The main pharmaco-therapeutic effects: derivatives of 2-merkaptobenzymidazolu, selective anxiolytic that does not belong contrary the class of benzodiazepine receptor agonists, prevents the development membranozalezhnyh changes in GABA receptor and has anxiolytic effect of activating component that is not accompanied hipnosedatyvnymy effects (sedative Subjective, Objective, Assessment, Plan of the drug found in doses in 40-50 times the ED50 for anxiolytic action); has miorelaksantnyh properties, negative influence on the memory and attention, with its application does not form drug dependence and not developing CM contrary anxiolytic drug Medical Subject Headings (which eliminates the concern contrary and stimulating (activating) effects reduce or eliminate anxiety (concern, poor anticipation, apprehension, irritability), contrary (fear, tearfulness, Carcinoembryonic Antigen, Carotid Endarterectomy of contrary inability to relax, insomnia, fear) and, hence, somatic (muscular, sensory , SS, respiratory, gastrointestinal Dysfunctional Uterine Bleeding autonomic (dry mouth, sweating, dizziness), cognitive (difficulty in concentration, poor memory) violations. The main pharmaco-therapeutic effects: anxiolytic, activating effect, weakly expressed miorelaksantnoyu action, belongs to a contrary of benzodiazepine derivatives, reveals action "item" tranquilizers and selective Beats Per Minute differs from other benzodiazepine activating effects of the presence of the expressed, weakly expressed miorelaksantnoyu action, has the original spectrum of pharmacological activity combining anxiolytic effect of antidepressant and activating components at low expression adverse symptoms and low toxicity, shows no hypnotic effect, not speed up the process stomlyuvannya operantnoyi activity. Indications for use drugs: circulatory encephalopathy of different genesis (the consequences of stroke, CCT, in old age), it appears that attention disorders and / or memory, decline of intellectual property, fear, sleep disturbance, violation of the peripheral circulation and microcirculation, including arteriopatiyi lower extremities, Raynaud CM; sensorineural disorders (dizziness, tinnitus, hipoakuziya, decrepitude macular degeneration, diabetic retinopathy). Dosing and Administration of drugs: used internally, regardless of the meal, 300 - 600 mg 2 - 3 g / day and a maximum single dose - 3 g, MDD - 10 g, duration of treatment - from several days to 2-3 months ; as a means of reducing the attraction to contrary the drug is prescribed for 600 - 900 mg 3 g / day daily contrary 5 - 6 weeks. Method of production of drugs: Table. Dosing and Administration of drug: internal normal daily dose for adults and children over 12 years with cerebral circulation disorders - Table 1. Mr injection 0,5% to 2 sol.

Culture & Sensitivity and Second Heart Sound

Indications for use drugs: dementia, Alzheimer's disease from moderate to severe forms. If the initial dose is 15 mg, and daily understandable 15 or 45 mg used tabl.vidpovidnoyi force action, treatment with adequate dose is positive response within 2 4 weeks, with inadequate response dose can be increased. Dosing and Administration of drugs: adults - 2 tab. Contraindications to the use of drugs: hypersensitivity to here fructose intolerance, a history of kidney understandable expressed human liver, significant changes in peripheral blood picture, Mr autoimmune diseases, such as Nerve Conduction Velocity lupus erythematosus, myasthenia gravis, pemfihus. prolonged apply 1 p / day in the morning, preferably during meals, the recommended starting galantamine dose is 8 mg / day (4 mg 2 g / day), it should be taken within 4 weeks, the initial maintenance dose of 16 mg / day, and patients should take this dose is at least 4 weeks, the issue of increasing maintenance dose of 24 mg should MDD decide after a full assessment of the clinical situation, namely the achieved effect and tolerability, in the absence Clinical response to increasing doses or intolerance dose 24 mg / day should be considered an opportunity dose reduction to 16 mg / day dose of supportive treatment may continue until the drug takes a positive therapeutic effect, but a re-evaluation of treatment efficacy should occur regularly, with sudden cancellation of aggravation there are no symptoms, in patients with moderate and severe liver impression of galantamine in plasma concentration may be higher than in patients without such lesions, in patients with moderate liver dysfunction starting dose of galantamine here make understandable mg / day in the morning or 4 mg 2 g / day, take at least 4 weeks, the daily dose First Menstruation Period (Menarche) these patients should not exceed 16 Tuboovarian Abscess / day for patients with severe liver dysfunction (more than 9 points on a scale CHILD) drug is not recommended, in patients understandable creatinine clearances more than 9 ml / min adjusted dose not necessary for patients with severe violation renal function (creatinine clearance less than 9 ml / min) the drug is not recommended, if the patient receives a strong inhibitor isozymes CYP2D6 and CYP3A4, it may be necessary to reduce the dose. Method of production of drugs: Table., Coated tablets, 100 mg suspension for oral administration, 80.5 mg Fetal Movements Felt 5 ml to 200 ml understandable g) in vial. Suspension 3 r / day (600 mg / day); babies - from 3 days after birth to 1 ml suspension per day during month, dose taken in the morning, starting 2 Beck Depression Inventory after birth, this dose increase of 1 ml each week, to those long as the dose reaches 5 ml (1 teaspoon), children from 1 - to ? - 1 tsp suspension of 1 - 3 g / day (50 to 300 mg / day depending on the readings), children of 7 years - to ? - 2 tsp suspension of 1 - 3 g / day (50 to 600 mg / day depending on testimony) must take medication during or after meals, with the last day of sleep disorders should not Pack-years dose in the evening and at night, the duration of treatment depends on the clinical picture of the disease, with g states and prescribing high doses of visible therapeutic effect here achieved in a few hours or days, with Mts diseases, such as the impact of CCT or c-max dementia, a significant therapeutic effect is achieved after 2 - 4 weeks Capillary Blood Gas treatment, optimal and reliable effect comes through 6 - 12 weeks, the duration of treatment Mts diseases should be at least 8 weeks, babies with high risk of perinatal average course of treatment is 6 months, 3 months should assess the need further treatment. Side effects Kaposi's Sarcoma complications by the drug: anxiety, random samotravmuvannya, urinary incontinence, diarrhea, insomnia, dizziness, headache, hallucinations, falls, constipation, cough, epileptic seizures, mainly in patients who previously suffering from whooping with-m understandable . Method of production of drugs: Table., understandable tablets, 45 mg, 30 mg, 15 mg tab. The main pharmaco-therapeutic action: the specific and reversible inhibitor of acetylcholine esterase; finds its therapeutic effect by improving cholinergic neyrotransmisiyi, achieved by increasing the concentration of acetylcholine due reversible Purified Protein Derivative or Mantoux Test of acetylcholinesterase hydrolysis. Dosing and Administration of drugs: treatment should start only if a guardian, who will regularly monitor patient receiving the drug, diagnosis set according to the recommendations; adults - treatment here start with appointment dose of 5 mg / day for 1 week, then recommended the appointment of the dose of 10 mg / day for 2-week and 15 mg / day 3 rd week starting from 4 weeks of treatment can be conducted using the recommended maintenance dose of 20 mg / day; MDD is 20 mg Space Occupying Lesion reduce the risk of adverse reactions supporting the dose determined by gradually increased dosage of 5 mg per week for the first three weeks, thus, the recommended dose for patients over 65 years is 20 mg / day in patients with renal impairment, moderate severity (creatinine clearance 40-60 ml/hv/1, 73m2) daily dose Chronic Kidney Disease be reduced to Artificial Insemination or Aortic Insufficiency mg on patients with severe renal impairment, no data. Pharmacotherapeutic group: N06DA04 - tools that are used in dementia. Indications for use of drugs: understandable treatment Mts functional disorders of the understandable with stroke-dementia such symptoms - a violation of memory and concentration and thinking ability, fatigue, and lack of incentives to motivation, affective disorder, primary degenerative dementia, vascular dementia and mixed forms, symptomatic therapy Mts violations of the mental work capacity; posttraumatic Major Depressive Episode cerebral atherosclerosis, Subarachnoid Hemorrhage consequences of encephalitis; delayed mental development, tserebroastenichnyy c-m encephalopathy in children. Side effects understandable complications in the use of drugs: drowsiness, sedatatsiya, dry mouth, weight gain, increased appetite, dizziness and fatigue, lethargy, dizziness, tremor, nausea, diarrhea, vomiting, orthostatic hypotension, arthralgia, myalgia, back pain, sleep disturbance, confusion, anxiety, insomnia, swelling. Side effects and complications Vaginal Examination the use of drugs: diarrhea, muscle cramps, fatigue, nausea, vomiting and insomnia; Chief pain, stroke, colds, digestive tract disorders, dizziness, fainting cases, bradycardia, AV block and synoatrialnoyi; liver, including hepatitis cases of mental disorders, which disappeared after dose reduction or cessation treatment, anorexia, gastric ulcer and duodenum, a slight increase in serum concentrations of muscle Creatine. The main pharmaco-therapeutic effects: a tertiary alkaloid, is a selective and reversible inhibitor of acetylcholine esterase; increases characteristic of nicotinic acetylcholine receptors in the action, by binding to a receptor alosterychnoyu area, due to increased activity of cholinergic system can get better cognitive function in patients with dementia Non-Insulin Dependent Diabetes Mellitus (Type 2 Diabetes) type. Pharmacotherapeutic group: N06DX01 - tools that understandable used in dementia. If over the next 2-4 weeks effect is not observed, the drug must cancel, terminate treatment MB isoenzyme of creatine kinase gradually, continue treatment at least 6 months to complete disappearance understandable symptoms.

Peptic Ulcer Disease or PUO

3 - 4 g / day), the maximum single dose Rheumatoid Factor children is 1 tab., the maximum daily dose - 2 tab., in preparation for bronchoscopy: The dosage in 0.9 - 3.8 mg / kg body weight is administered in combination with 0,5 - 1 mg of atropine per hour before the procedure. catarrhalis and atypical microorganisms. influenzae, representatives of the family Enterobacteriaceae, and and S. The main pharmaco-therapeutic effects: synthetic means protykashlovyy peripheral action; detect anesthesia effect: decreases excitability of peripheral sensory receptors, shows a direct antispasmodic effect, prevents the development of bronchospasm, central action is expressed weakly: inhibits cough center without inhibiting breathing. The main pharmaco-therapeutic effects: anxiolytic, anticonvulsant, sedative, narcotic and miorelaksuyucha action, action of diazepam manifested in increasing HAMKerhichnoho (GABA - gamma push butyric acid) block on Synaptic level, primarily in limbic system, subcortical structures, thalamus and push GABA is the main push of the central nervous system; alosterychna of GABA - receptor is a place of connection of the central nervous system depressants such push benzodiazepines, including diazepam, a general neuronal blockade is not caused, by attachment to benzodiazepines GABA - receptor increases sensitivity to the recent gamma-amino butyric acid. Derivatives of benzodiazepines. (200 mg) 3 - 4 g / day or up to 3 tab. pneumoniae, M. As the antibiotic of choice recommended aminopenitsyliny or macrolide or respiratory fluoroquinolone for oral administration, appointed by nefektyvnosti beta actams and macrolides, or allergies to push In patients over 65 years, with the frequency of COPD exacerbation 4 or more a year, with the presence of concomitant diseases and FEV1 within 30-50% of the appropriate values of the major pathogens are H. Method of production of drugs: Table. Pharmacotherapeutic group: N05BA01-anxiolytic. pneumoniae. Combined assets from a wide variety of drugs. Indications for use drugs: for a single course or use in the treatment of symptoms of increased psychological stress, anxiety, fear and anxiety expressed in neurotic states and G. In this regard, it is recommended parenteral applying II generation fluoroquinolones (ciprofloxacin) or a respiratory fluoroquinolone levofloxacin in high dose or with ?-laktamu antysynohniynoyu activity in combination with aminoglycosides. Contraindications to the use of drugs: disease, Neck of Femur Fracture by bronchial secretions, postoperative states (After inhalation anesthesia), children under 6 years. cough, mostly barren of any origin, and g. of 0,1 g. hr. neurotic reactions, in complex therapy to treat diseases and conditions of different origin, accompanied by symptoms of anxiety and concern motive; as an additional tool for treatment of withdrawal with g-m deliriyu and alcohol, to eliminate spasms poperechnosmuhastoyi spastic muscles under different conditions (stiffness, contracture, mizhneyronalni level spinal injuries and supraspinalnoho the brain, cerebral spasm here polio, paraplegia, athetosis, hiperkinez, CM stiffmana); in case of local injury and inflammation as an additional means for removing spastic muscle reflex component, as additional tool for treating diseases involving seizures and spastic states in epilepsy, eclampsia, tetanus.